Trials / Completed
CompletedNCT01755429
To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients
A Research Study to Describe the Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS). An Assessment of Two Case Studies
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2 (actual)
- Sponsor
- Alexion Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This protocol is intended to formally collect data on the treatment of aHUS with eculizumab in Japanese patients.
Conditions
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2012-05-01
- Completion
- 2012-07-01
- First posted
- 2012-12-24
- Last updated
- 2012-12-24
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01755429. Inclusion in this directory is not an endorsement.